Cargando…

The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature

Background and objectives: Although it is very uncommon, medication-induced osteonecrosis of the jaw (also known as MRONJ) can have serious consequences. Traditionally, this adverse event has been recognised in patients who were treated with bisphosphonate (BP) drugs. Nevertheless, in recent years,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sacco, Roberto, Akintola, Oladapo, Sacco, Nicola, Acocella, Alessandro, Calasans-Maia, Monica Diuana, Maranzano, Massimo, Olate, Sergio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223182/
https://www.ncbi.nlm.nih.gov/pubmed/37241200
http://dx.doi.org/10.3390/medicina59050968
_version_ 1785049880319754240
author Sacco, Roberto
Akintola, Oladapo
Sacco, Nicola
Acocella, Alessandro
Calasans-Maia, Monica Diuana
Maranzano, Massimo
Olate, Sergio
author_facet Sacco, Roberto
Akintola, Oladapo
Sacco, Nicola
Acocella, Alessandro
Calasans-Maia, Monica Diuana
Maranzano, Massimo
Olate, Sergio
author_sort Sacco, Roberto
collection PubMed
description Background and objectives: Although it is very uncommon, medication-induced osteonecrosis of the jaw (also known as MRONJ) can have serious consequences. Traditionally, this adverse event has been recognised in patients who were treated with bisphosphonate (BP) drugs. Nevertheless, in recent years, it has been established that individuals having treatment with various types of medications, such as a receptor activator of nuclear factor kappa-Β ligand inhibitor (denosumab) and antiangiogenic agents, have had the same issue. The purpose of this research is to determine if the application of human amniotic membrane (hAM) may be used as a therapy for MRONJ. Material and Methods: A multi-source database (MEDLINE, EMBASE, AMED, and CENTRAL) systematic search was performed. The major objective of this study is to obtain an understanding of the efficacy of hAM when it is employed as a treatment modality for MRONJ. The protocol of this review was registered in the INPLASY register under the number NPLASY202330010. Results: The authors were able to include a total of five studies for the quality analysis, whereas for the quantity evaluation, only four studies were eligible. A total of 91 patients were considered for the investigation. After treatment with human amniotic membrane (hAM), a recurrence of osteonecrosis was observed in n = 6 cases (8.8%). The combined efficacy of surgical therapy and the use of hAM resulted in an overall success rate of 91.2%. Intraoperative complications were only documented in one article, and they were mostly caused by the positioning of the hAM, which led to wound breakdown at the surgical site. Conclusions: Based on the small amount of data and low-quality research included in this study, using human amniotic membranes to treat MRONJ might represent a feasible option. Nevertheless, further studies with a wider patient population are required to understand the long-term impacts.
format Online
Article
Text
id pubmed-10223182
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-102231822023-05-28 The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature Sacco, Roberto Akintola, Oladapo Sacco, Nicola Acocella, Alessandro Calasans-Maia, Monica Diuana Maranzano, Massimo Olate, Sergio Medicina (Kaunas) Review Background and objectives: Although it is very uncommon, medication-induced osteonecrosis of the jaw (also known as MRONJ) can have serious consequences. Traditionally, this adverse event has been recognised in patients who were treated with bisphosphonate (BP) drugs. Nevertheless, in recent years, it has been established that individuals having treatment with various types of medications, such as a receptor activator of nuclear factor kappa-Β ligand inhibitor (denosumab) and antiangiogenic agents, have had the same issue. The purpose of this research is to determine if the application of human amniotic membrane (hAM) may be used as a therapy for MRONJ. Material and Methods: A multi-source database (MEDLINE, EMBASE, AMED, and CENTRAL) systematic search was performed. The major objective of this study is to obtain an understanding of the efficacy of hAM when it is employed as a treatment modality for MRONJ. The protocol of this review was registered in the INPLASY register under the number NPLASY202330010. Results: The authors were able to include a total of five studies for the quality analysis, whereas for the quantity evaluation, only four studies were eligible. A total of 91 patients were considered for the investigation. After treatment with human amniotic membrane (hAM), a recurrence of osteonecrosis was observed in n = 6 cases (8.8%). The combined efficacy of surgical therapy and the use of hAM resulted in an overall success rate of 91.2%. Intraoperative complications were only documented in one article, and they were mostly caused by the positioning of the hAM, which led to wound breakdown at the surgical site. Conclusions: Based on the small amount of data and low-quality research included in this study, using human amniotic membranes to treat MRONJ might represent a feasible option. Nevertheless, further studies with a wider patient population are required to understand the long-term impacts. MDPI 2023-05-17 /pmc/articles/PMC10223182/ /pubmed/37241200 http://dx.doi.org/10.3390/medicina59050968 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Sacco, Roberto
Akintola, Oladapo
Sacco, Nicola
Acocella, Alessandro
Calasans-Maia, Monica Diuana
Maranzano, Massimo
Olate, Sergio
The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature
title The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature
title_full The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature
title_fullStr The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature
title_full_unstemmed The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature
title_short The Use of Human Amniotic Membrane (hAM) as a Treatment Strategy of Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis of the Literature
title_sort use of human amniotic membrane (ham) as a treatment strategy of medication-related osteonecrosis of the jaw (mronj): a systematic review and meta-analysis of the literature
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223182/
https://www.ncbi.nlm.nih.gov/pubmed/37241200
http://dx.doi.org/10.3390/medicina59050968
work_keys_str_mv AT saccoroberto theuseofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature
AT akintolaoladapo theuseofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature
AT sacconicola theuseofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature
AT acocellaalessandro theuseofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature
AT calasansmaiamonicadiuana theuseofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature
AT maranzanomassimo theuseofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature
AT olatesergio theuseofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature
AT saccoroberto useofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature
AT akintolaoladapo useofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature
AT sacconicola useofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature
AT acocellaalessandro useofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature
AT calasansmaiamonicadiuana useofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature
AT maranzanomassimo useofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature
AT olatesergio useofhumanamnioticmembranehamasatreatmentstrategyofmedicationrelatedosteonecrosisofthejawmronjasystematicreviewandmetaanalysisoftheliterature